163 related articles for article (PubMed ID: 37155841)
1. Antithetic effects of agonists and antagonists on the structural fluctuations of TRPV1 channel.
Sumino A; Zhao Y; Mukai D; Sumikama T; Puppulin L; Hattori M; Shibata M
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2301013120. PubMed ID: 37155841
[TBL] [Abstract][Full Text] [Related]
2. Understanding TRPV1 activation by ligands: Insights from the binding modes of capsaicin and resiniferatoxin.
Elokely K; Velisetty P; Delemotte L; Palovcak E; Klein ML; Rohacs T; Carnevale V
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E137-45. PubMed ID: 26719417
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat.
Bölcskei K; Tékus V; Dézsi L; Szolcsányi J; Petho G
Eur J Pain; 2010 May; 14(5):480-6. PubMed ID: 19800272
[TBL] [Abstract][Full Text] [Related]
4. Vanilloid agonist-mediated activation of TRPV1 channels requires coordinated movement of the S1-S4 bundle rather than a quiescent state.
Sun MY; Zhang X; Yu PC; Liu D; Yang Y; Cui WW; Yang XN; Lei YT; Li XH; Wang WH; Cao P; Wang HS; Zhu MX; Li CZ; Wang R; Fan YZ; Yu Y
Sci Bull (Beijing); 2022 May; 67(10):1062-1076. PubMed ID: 36546250
[TBL] [Abstract][Full Text] [Related]
5. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
Shimizu I; Iida T; Horiuchi N; Caterina MJ
J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039
[TBL] [Abstract][Full Text] [Related]
6. Rational design and validation of a vanilloid-sensitive TRPV2 ion channel.
Yang F; Vu S; Yarov-Yarovoy V; Zheng J
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3657-66. PubMed ID: 27298359
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for functional TRPV1/TRPA1 heteromers.
Fischer MJ; Balasuriya D; Jeggle P; Goetze TA; McNaughton PA; Reeh PW; Edwardson JM
Pflugers Arch; 2014 Dec; 466(12):2229-41. PubMed ID: 24643480
[TBL] [Abstract][Full Text] [Related]
8. Resiniferatoxin binds to the capsaicin receptor (TRPV1) near the extracellular side of the S4 transmembrane domain.
Chou MZ; Mtui T; Gao YD; Kohler M; Middleton RE
Biochemistry; 2004 Mar; 43(9):2501-11. PubMed ID: 14992587
[TBL] [Abstract][Full Text] [Related]
9. Capsaicin interaction with TRPV1 channels in a lipid bilayer: molecular dynamics simulation.
Hanson SM; Newstead S; Swartz KJ; Sansom MSP
Biophys J; 2015 Mar; 108(6):1425-1434. PubMed ID: 25809255
[TBL] [Abstract][Full Text] [Related]
10. Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin.
Raisinghani M; Pabbidi RM; Premkumar LS
J Physiol; 2005 Sep; 567(Pt 3):771-86. PubMed ID: 16037081
[TBL] [Abstract][Full Text] [Related]
11. Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
Ursu D; Knopp K; Beattie RE; Liu B; Sher E
Eur J Pharmacol; 2010 Sep; 641(2-3):114-22. PubMed ID: 20576527
[TBL] [Abstract][Full Text] [Related]
12. Opening of capsaicin receptor TRPV1 is stabilized equally by its four subunits.
Li S; Nguyen PT; Vu S; Yarov-Yarovoy V; Zheng J
J Biol Chem; 2023 Jun; 299(6):104828. PubMed ID: 37196769
[TBL] [Abstract][Full Text] [Related]
13. Heat-dependent opening of TRPV1 in the presence of capsaicin.
Kwon DH; Zhang F; Suo Y; Bouvette J; Borgnia MJ; Lee SY
Nat Struct Mol Biol; 2021 Jul; 28(7):554-563. PubMed ID: 34239123
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release.
Kim SR; Kim SU; Oh U; Jin BK
J Immunol; 2006 Oct; 177(7):4322-9. PubMed ID: 16982866
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of vanilloid sensitivity in TRPV1.
Gavva NR; Klionsky L; Qu Y; Shi L; Tamir R; Edenson S; Zhang TJ; Viswanadhan VN; Toth A; Pearce LV; Vanderah TW; Porreca F; Blumberg PM; Lile J; Sun Y; Wild K; Louis JC; Treanor JJ
J Biol Chem; 2004 May; 279(19):20283-95. PubMed ID: 14996838
[TBL] [Abstract][Full Text] [Related]
16. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
[TBL] [Abstract][Full Text] [Related]
17. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS
Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976
[TBL] [Abstract][Full Text] [Related]
18. Naloxone Is a Potential Binding Ligand and Activator of the Capsaicin Receptor TRPV1.
Melkes B; Markova V; Hejnova L; Marek A; Novotny J
Biol Pharm Bull; 2020; 43(5):908-912. PubMed ID: 32378567
[TBL] [Abstract][Full Text] [Related]
19. Cloning and pharmacological characterization of mouse TRPV1.
Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S
Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies.
Lee JH; Lee Y; Ryu H; Kang DW; Lee J; Lazar J; Pearce LV; Pavlyukovets VA; Blumberg PM; Choi S
J Comput Aided Mol Des; 2011 Apr; 25(4):317-27. PubMed ID: 21448716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
